Osteoarthritis Trial, Recruiting (NCT05495334)

Osteoarthritis Trial, Recruiting NCT05495334 Sponsor: Pacira Pharmaceuticals, Inc Condition: Osteoarthritis

Printed from Voxsanity (voxsanity.com.au) — NCT05495334 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Osteoarthritis

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

You are planning to receive treatment for knee pain caused by osteoarthritis — such as knee injections, nerve-blocking procedures, or knee replacement surgery — within 60 days of your screening visit
You are able to understand and fill out consent forms and questionnaires, in the opinion of the trial staff
You have access to a smartphone, computer, or tablet with internet to complete questionnaires through the trial's app or website

Who may not be able to join:

You are currently taking part in another research trial that would prevent you from receiving the standard knee osteoarthritis treatment or standard recovery care offered at the trial site
You are planning to have surgery on any joint or body part other than the specific knee being studied in this trial

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 8 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: 1-520-490-5355

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT05495334

Sponsor: Pacira Pharmaceuticals, Inc

Phase: Not Applicable

Status: Recruiting

Condition: Osteoarthritis

Trial contact: 1-520-490-5355

More information: https://clinicaltrials.gov/study/NCT05495334

Eligibility summary (AI generated)

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

You are planning to receive treatment for knee pain caused by osteoarthritis — such as knee injections, nerve-blocking procedures, or knee replacement surgery — within 60 days of your screening visit
You are able to understand and fill out consent forms and questionnaires, in the opinion of the trial staff
You have access to a smartphone, computer, or tablet with internet to complete questionnaires through the trial's app or website

Who may not be able to join:

You are currently taking part in another research trial that would prevent you from receiving the standard knee osteoarthritis treatment or standard recovery care offered at the trial site
You are planning to have surgery on any joint or body part other than the specific knee being studied in this trial

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 8 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

Pacira Pharmaceuticals, Inc

Registry

ClinicalTrials.gov

Start date

23 September 2021

Est. completion

30 June 2032

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Pain intensity and interference scores via NRS (Numeric Rating Scale); Pain intensity and interference scores via BPI-sf (Brief Pain Inventory-short form); Opioid use via pre-and post-treatment analgesic medication use log; Functional status via KOOS-JR (Knee injury and Osteoarthritis Outcome Score for Joint Replacement); Functional status via SANE (Single Assessment Numeric Evaluation); Quality of Sleep via PROMIS-SD (PROMIS - Sleep Disturbance - Short Form 8b); Adverse events related to pain therapies; General HRQOL via PROMIS-10 (PROMIS GLOBAL-10); Patient Satisfaction; Physical therapy uti...

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 8 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov